TABLE 5.
Variables | Occurrence of NTOVCF | |
---|---|---|
R 2 | P value | |
P1NP (ng/ml) | −0.131** | 0.007 |
β‐CTX (ng/ml) | 0.277** | 0.000 |
β‐CTX/P1NP (%) | 0.368** | 0.000 |
25(OH)D (ng/ml) | −0.157** | 0.001 |
PTH (pg/ml) | −0.288** | 0.000 |
TP (g/L) | −0.132** | 0.006 |
ALB (g/L) | −0.420** | 0.000 |
ALB degree (n)* | 0.429** | 0.000 |
TC (mmol/L) | 0.157** | 0.001 |
HDL‐C (mmol/L) | 0.284** | 0.000 |
RBC (×1012/L) | −0.190** | 0.000 |
HB (g/L) | −0.283** | 0.000 |
HB degree (n)* | 0.220** | 0.000 |
ACP (U/L) | 0.244** | 0.000 |
NACP (U/L) | 0.405** | 0.000 |
BMD (T‐score) | −0.410** | 0.000 |
BMD degree (n)* | 0.369** | 0.000 |
Daily activity (n)* | −0.225** | 0.000 |
FDR (%) | 0.598** | 0.000 |
FDR degree (n)* | 0.209** | 0.000 |
CSA (cm2) | −0.613** | 0.000 |
LMM (cm2) | −0.729** | 0.000 |
LMF (cm2) | 0.289** | 0.000 |
Abbreviations: β‐CTX, b‐C‐terminal telopeptide of type I collagen; ALB, serum albumin; AUC, area under the ROC curve; BMD, bone mineral density; CI, confidence interval; CSA, cross‐sectional area; DE, diagnostic efficiency; FDR, fatty degeneration ratio; HB, hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; LMF, lumbar muscle fat; LMM, lumbar muscle mass; NACP, non‐prostatic acid phosphatase; NPV, negative predictive value; P1NP, propeptide of type I procollagen; PPV, positive predictive value; PTH, Parathyroid Hormone; R 2, correlation coefficient; TC, total cholesterol.
Notes: All P values were calculated with the Spearman correlation analysis. **P value < 0.01 was considered the correlation was particularly significant.